Libenzapril
Libenzapril (CGS 16617) is a potent and selective angiotensin-converting enzyme (ACE) inhibitor. It is widely used in cardiovascular research to investigate hypertension, myocardial injury, and heart failure models in both in vivo and in vitro experimental systems.
Product Specifications
CAS Number
109214-55-3
Product Name Alternative
Libenzapril, CGS-16617, CGS16617, CGS 16617, Abutapril, ACE, Angiotensin-converting Enzyme, AngiotensinconvertingEnzyme (ACE), AngiotensinconvertingEnzyme, Angiotensinconverting Enzyme (ACE), Angiotensin-converting Enzyme (ACE)
Field of Research
Metabolism Research
Purity
98.74% (May vary between batches)
Solubility
DMSO:< 1 mg/mL (insoluble or slightly soluble) ; H2O:100 mg/mL (275.17 mM)
Smiles
C (C (O) =O) N1C=2C (CC[C@H] (N[C@@H] (CCCCN) C (O) =O) C1=O) =CC=CC2
Molecular Formula
C18H25N3O5
Molecular Weight
363.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC417744 20 µg
OSCP (ITGBL1) (NM_004791) Human Over-expression Lysate
Sign In for Pricing
View Details 